Boston — Language Scientific has received a second U.S. patent covering technology used by its RxTran platform to help pharmacists verify translated prescription instructions even when they cannot read the language provided to the patient.
Patent US 12,602,554, titled “Systems and Methods for Producing Reliable Translation in Near Real-Time,” was granted April 14, 2026, and is assigned to Language Scientific.
RxTran said the technology is designed to produce and verify prescription translations before they are provided to patients. The system breaks source directions into semantic structures, matches them against a controlled library of pre-translated phrases and allows pharmacists to confirm the intended meaning in English.
“Fast translation and verifiable translation aren’t the same thing. A free tool can give you a Vietnamese sentence in a second, but no one at the counter can tell you whether it’s safe to hand to a patient. We built this so the pharmacist stays in control,” said Leonid Fridman, Founder and President of Language Scientific and RxTran.
The new patent expands on the company’s earlier intellectual property by adding a correction loop that allows pharmacists to revise source wording and resubmit it for processing.
It also covers machine learning models that identify portions of text, match them to stored phrases and rank potential candidates. According to RxTran, artificial intelligence is limited to suggesting English paraphrases and does not generate the final patient-facing translation.
The patent also includes claims covering speech input, allowing pharmacists to dictate instructions into the system.
RxTran said its translation library contains more than one million pre-translated prescription directions across 26 languages. Each translation undergoes a five-step review process that includes forward translation, editing, back translation, reconciliation and approval by a licensed bilingual pharmacist.
The company said the technology can also be applied beyond pharmacy labels to hospital discharge instructions, patient communications and emergency evacuation instructions.
RxTran integrates with a range of pharmacy software systems and also offers access through a web-based platform for pharmacies without direct integrations.
“What this patent protects is the part that matters most – a pharmacy’s ability to stand behind every translation it hands out,” said Sharon Blank, Chief Executive Officer of Language Scientific and RxTran.
